Abel Hall »

Lineage Cell Therapeutics In shares owned by Abel Hall

Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Abel Hall from 13F filings

Historical chart of Abel Hall investment in Lineage Cell Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including Lineage Cell Therapeutics In held by Abel Hall consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lineage Cell Therapeutics In by Abel Hall

Quarter filed Position value Share count Share price at filing
2026-09-30 $13k 13k 0.96

More positions owned by Abel Hall

Dimensional Etf Trust Us Cor Equ 2 Etf
NVIDIA Corporation (NVDA)
Apple (AAPL)
Dimensional Etf Trust Intl Core Equity (DFIC)
Dfa Invt Dimensions Group In U.s. Sml Cp Val (DFSV)
Microsoft Corporation (MSFT)
Dfa Invt Dimensions Group In U.s. High Relati (DUHP)
Dimensional Etf Trust Us Core Eqt Mkt (DFAU)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Dimensional Etf Trust Intl Small Cap V (DISV)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Dimensional Etf Trust Intl High Profit (DIHP)

View all positions for Abel Hall

Top funds holding Lineage Cell Therapeutics In

Broadwood Capital
BlackRock
Vanguard Capital Management
Defender Capital
Geode Capital Management
Raffles Associates
Fifth Third Bancorp
Millennium Management
State Street Corporation
Vanguard Fiduciary Trust
Northern Trust
Renaissance Technologies
Marshall Wace
Vanguard Portfolio Management
UBS Group

View all funds holding Lineage Cell Therapeutics In